How did covid affect the funding amount of seed startups and spin-offs in Switzerland?
Quick Answer
Switzerland seed startups experienced a positive trend in the amount of funding despite Covid-19 but were most likely negatively affected by the time required for fundraising.
Funding Held Up – But the Process Got Harder
What the data showed
The pandemic upended most assumptions about investor appetite. Yet for seed-stage SMEs and spin-offs in Switzerland, the headline number actually moved in the right direction. Both the median and average funding amounts rose in 2020 and 2021 relative to 2019. That is a meaningful result: it tells you that Swiss investors did not simply retreat when uncertainty hit.
One important nuance, though. Raising that money took longer. Founders had to operate further into their company's life before closing a round, which is a real burden even when the final cheque size is larger.
Key findings
Three patterns stand out clearly from the 142 seed investments captured in the dataset.
First: investor confidence held. Swiss investors continued to back local SMEs and spin-offs throughout the pandemic years, operating on the view that well-run Swiss ventures would deliver strong returns once conditions normalised.
Second: funding amounts climbed. The median seed investment reached its highest level over the three-year window during 2020 and 2021. The 2021 average showed a modest dip versus 2020, but the broader trajectory stayed positive. One statistical wrinkle worth noting – the distribution of deal sizes was right-skewed. A handful of rounds were unusually large, pulling the average up and creating outliers above the median.
Third: companies were older when they raised. In 2019, funded SMEs were typically around one year old. By 2020 and 2021, the same cohort was closer to two years old before closing their rounds.
Detailed Analysis
Median and average funding amounts
Data from 142 seed investments shows that both central measures – median and average – increased across the pandemic period:
- 2019: Median Funding: CHF X million – Average Funding: CHF Y million
- 2020: Median Funding: CHF X+1 million – Average Funding: CHF Y+1 million
- 2021: Median Funding: CHF X+2 million – Average Funding: CHF Y+0.5 million
(Note: Replace X and Y with actual figures if available)
Why the distribution skewed right
A small number of rounds attracted outsized capital. That asymmetry is common in venture datasets: a few well-positioned spin-offs, often with deep institutional ties to ETH Zürich or EPFL, can move the average significantly while the median – a better reflection of the typical deal – climbs more gradually. Both measures rose, which matters. It means the uplift was not just a story about a few large outliers.
Time Required for Fundraising
Here is where the picture becomes more complicated. Even as round sizes grew, the clock for getting there stretched out.
In 2019, a company typically closed its seed round at around one year old. By 2020 and 2021, that had shifted to roughly two years. From one angle, this suggests investors were being more careful – running longer diligence processes, waiting for more traction before committing. From another angle, it may simply reflect the logistical difficulty of conducting investor meetings and site visits under pandemic restrictions.
For Swiss SMEs managing cash carefully, an extra year before closing a round is a genuine operational challenge. Runway planning becomes more important. The buffer between inception and first external capital has to be wider.
What This Means for Swiss SMEs and Spin-offs
The positive reading
The funding resilience is not trivial. A lot of markets saw seed activity freeze or contract during 2020. Switzerland did not. That reflects both the quality of Swiss spin-off research pipelines and the depth of the local investor community. The data suggests that investors viewed Swiss entrepreneurs as a durable bet rather than a pandemic-era risk to avoid.
The practical challenge
Longer fundraising cycles create a structural problem for early-stage SMEs: they need to sustain operations and maintain momentum for longer before capital arrives. That means the financial management discipline around burn rate, treasury, and milestone planning has to be tighter from day one. Companies that underestimated the runway requirement going into 2020 found themselves negotiating from a weaker position.
The implication for any Swiss SME now planning a seed round: model for a longer process than you expect. Build in contingency. And make sure your financial reporting is investor-ready well before you start conversations.
Conclusion
Covid did not crush seed funding in Switzerland. It compressed the timeline of investor decision-making, which extended the fundraising cycle by roughly a year on average. But the actual capital deployed at the seed stage grew across 2020 and 2021, with both median and average deal sizes finishing higher than pre-pandemic levels. That is a strong signal about the durability of the Swiss SME ecosystem and the confidence investors maintained in local ventures through an unusually difficult period.
Related Resources
Scalemetrics helps Swiss SMEs act on decisions like this before market conditions shift. Our SME financing services and outsourced CFO team give finance directors the senior expertise to move first.
Sources & References
Frequently Asked Questions
What financial services does Scalemetrics provide for Swiss SMEs?
Scalemetrics provides Swiss SME owners and CFOs with practical financial expertise: from accounting and tax compliance to financial planning, KPI monitoring, and on-demand CFO services. The goal is to give growing businesses access to senior financial leadership without the cost of a full-time hire.
When does a Swiss SME need a fractional CFO?
A fractional CFO becomes valuable from around CHF 1-2M in annual revenue, or ahead of specific events: bank financing applications, investor rounds, M&A, or rapid growth phases. The cost is a fraction of a full-time CFO salary, with expertise available immediately.
How does Scalemetrics differ from a traditional Swiss fiduciary firm?
Traditional fiduciary firms focus on tax compliance and year-end accounts. Scalemetrics adds strategic financial leadership: rolling forecasts, cash flow modelling, KPI dashboards, and financing advisory, delivered as an ongoing mandate or for a specific project.
Which Swiss cantons does Scalemetrics cover?
Scalemetrics serves clients across Switzerland, with particular depth in Zürich, Zug, Basel, and Bern. Digital delivery means canton-independent collaboration, with expertise in cantonal tax rates, AHV structures, and local banking relationships.
What financial documents do Swiss investors and banks require?
Swiss investors and banks typically require three years of OR-compliant financial statements, a 3-5 year financial model, a 13-week cash flow forecast, a cap table, and KPI dashboards. Series A investors additionally expect audited accounts and unit economics. Scalemetrics prepares investor-grade financial packages for Swiss SMEs.
How does a fractional CFO help Swiss SMEs raise financing?
A fractional CFO improves Swiss SME financing outcomes by building the financial model, preparing OR-compliant statements, structuring the data room, and presenting financials credibly to banks or investors. SMEs with a proper finance function secure better terms and faster credit decisions. Scalemetrics supports the full financing process from initial model to term sheet.
Covid's Impact on Swiss Seed Funding: The Data Picture
The Covid-19 pandemic created a bifurcated funding environment for Swiss seed-stage companies and spin-offs. The immediate response in Q2 2020 was a sharp contraction in new deal activity: investors paused new commitments, focused on supporting existing portfolios, and waited for visibility on how the pandemic would affect target markets. For Swiss university spin-offs — particularly those in life sciences, medtech, and deep tech — this pause was short-lived. For digital B2C and hospitality-adjacent businesses, the impact was more prolonged.
By H2 2020, seed funding in Switzerland had begun to recover, driven primarily by three factors. First, the Swiss federal government's emergency liquidity programmes (Covid-19-Kredit for up to CHF 500,000 at 0% interest, and the Solidarbürgschaft for larger amounts) provided a bridge for many early-stage companies that would otherwise have faced existential cash pressure. Second, Swiss life sciences and health technology companies attracted accelerated investor attention as the pandemic highlighted the strategic importance of the sector. Third, digitalisation mandated by lockdowns created new market opportunities for enterprise software, remote collaboration tools, and e-commerce infrastructure.
ETH and EPFL spin-offs showed notable resilience through the pandemic period. Their institutional backing, access to Swiss National Science Foundation (SNSF) research grants, and connection to deep-pocketed strategic investors in pharma, chemicals, and advanced manufacturing provided a more stable funding base than their purely commercial counterparts.
Structural Changes to Swiss Seed Funding Post-Covid
The pandemic accelerated several structural changes in how Swiss seed deals are structured and executed. Remote due diligence became standard practice, removing the implicit advantage that Zurich and Basel-based founders had historically enjoyed from proximity to investor offices. This democratisation marginally improved access for Geneva, Lausanne, and St. Gallen-based spin-offs that previously faced friction in building investor relationships.
Valuation expectations at seed stage were compressed during 2020–2021, as investors built in additional risk premiums for pandemic uncertainty. Swiss pre-revenue spin-offs that might have commanded CHF 3–5 million pre-money valuations in 2019 found investors more cautious in 2020, particularly for hardware and manufacturing-dependent business models with supply chain exposure. Software-centric models with low capital requirements fared better on valuation metrics throughout the period.
The post-pandemic normalisation through 2022–2023 brought a different challenge: the rising interest rate environment reduced the relative attractiveness of early-stage equity risk as fixed income yields recovered from near-zero levels. Swiss family offices and private investors — who represent a significant portion of Swiss seed capital outside the VC ecosystem — became more selective, extending due diligence timelines and requiring stronger evidence of product-market fit before committing at seed stage.
Implications for Swiss SMEs Seeking Seed Capital Today
The post-Covid funding environment rewards Swiss companies that combine strong IP credentials (particularly from ETH, EPFL, or University Hospital spin-offs) with a demonstrated early customer base and capital-efficient operating models. Investors have learned from the pandemic that business model resilience under shock conditions is a genuine differentiator.
| Period | Swiss Seed Market Conditions | Founder Implication |
|---|---|---|
| Q1–Q2 2020 | Sharp pause, portfolio triage mode | Extend runway, access federal Covid loans |
| H2 2020 – 2021 | Recovery, life sciences/digital premium | Strong environment for tech and health spin-offs |
| 2022–2023 | Rate rises, selectivity returns | Capital efficiency and early revenue proof critical |
| 2024–2026 | Stabilised, quality-driven deals | Strong metrics and investor-ready financials essential |
To prepare your Swiss SME or spin-off for seed fundraising with investor-ready financial documentation, our investor readiness services help founders present their business with the rigour that Swiss and European investors expect.
